Related Experiment Video
Updated: Jul 5, 2025

08:30
Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells
Published on: January 7, 2020
13.0K
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq
Daniel V Brown1, Casey J A Anttila2, Ling Ling2
1The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade VIC, Melbourne 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, Melbourne 3010, VIC, Australia.
Genomics
|January 14, 2024
Summary
Choosing the right sample multiplexing reagents is crucial for high-quality single-cell RNA sequencing (scRNA-Seq) data. This study compares reagents and protocols, offering guidance for accurate and cost-effective scRNA-Seq experiments.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Single-cell RNA sequencing (scRNA-Seq) is vital for dissecting cellular heterogeneity.
- Sample multiplexing reagents significantly influence scRNA-Seq data quality and experimental outcomes.
Purpose of the Study:
- To compare the performance of different multiplexing reagents (MULTI-Seq, Hashtag antibody, CellPlex) across diverse sample types.
- To evaluate demultiplexing algorithms and assess the impact of laboratory workflow optimizations.
- To investigate methods for enhancing sequencing value in highly multiplexed scRNA-Seq experiments.
Main Methods:
- Comparative analysis of MULTI-Seq, Hashtag antibody, and CellPlex reagents using PBMCs, mouse brain, and PDX samples.
- Evaluation of various demultiplexing algorithms on scRNA-Seq data.
- Assessment of fixed scRNA-Seq kits, including the Parse Biosciences kit.
- Exploration of CRISPR-based gene destruction for optimizing sequencing resources.
Main Results:
- All tested multiplexing reagents performed well on robust cell types but showed signal-to-noise issues with delicate samples.
- Demultiplexing algorithm performance varied based on data quality.
- Laboratory workflow improvements, such as titration and rapid processing, are critical for optimal results.
- The Parse Biosciences kit demonstrated advantages for fragile samples.
Conclusions:
- Selection of appropriate sample multiplexing reagents and protocols is essential for successful scRNA-Seq studies.
- Optimized workflows and reagent choices can improve data accuracy and reduce costs in scRNA-Seq.
- CRISPR-based gene destruction offers a strategy to enhance sequencing efficiency in complex experiments.

